Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

The effect of probiotic supplementation on sexual function in premenopausal and menopausal women: a randomized controlled clinical trial.

  • 2025-12-02
  • Scientific reports 16(1)
    • Roghayyeh Valizadeh
    • Fatemeh Borhani
    • Fatemeh Shabani
    • Mojgan Mirghafourvand

Study Design

Type
Randomized Controlled Trial (RCT)
Population
64 premenopausal and menopausal women with sexual dysfunction
Methods
Double-blind randomized clinical trial, 8 weeks of 250 mg capsule containing 3×10^9 CFU/cap of Lactobacillus acidophilus once daily
Blinding
Double-blind
Duration
8 weeks
Funding
Unclear
  • Rigorous Journal
Sexual activity is an important component of women's lives, which may affect their quality of life. The aim of this study was to investigate the effect of probiotic supplementation on sexual function (primary outcome) and quality of life (secondary outcome). This double-blind randomized clinical trial was conducted on 64 premenopausal and menopausal women with sexual dysfunction attending health centers in Tabriz, Iran. Participants were randomly assigned to the probiotic and placebo groups using block randomization method. The probiotic group received a 250 mg capsule containing 3 × 109 CFU/cap of Lactobacillus acidophilus, while the placebo group received a 250 mg capsule containing regular corn starch once daily for 8 weeks. The Female Sexual Function Index (FSFI) and the Menopause Quality of Life (MENQoL) questionnaire were completed before and eight weeks after the intervention. For comparing the mean sexual function and Menopause quality of life scores between groups, independent t, ANCOVA and Mann-Whitney U tests were used. Before intervention, no significant differences were observed between the probiotic and placebo groups in terms of FSFI and MENQoL total scores or their subscales (P > 0.05). After 8 weeks, the probiotic group had a significantly higher total FSFI score compared with the placebo group (median 19.1 vs. 18.2, P = 0.038). Also, the total MENQoL score was significantly lower in the probiotic group compared with placebo group (mean 25.1 vs. 30.9, P < 0.001). Our results indicated that probiotic consumption improves sexual function and Menopause quality of life. For a definitive conclusion, it is recommended that further studies be conducted in this area.Trial registration Iranian Registry of Clinical Trials (IRCT): IRCT20120718010324N83. Date of registration: 11 May 2024; URL: https://irct.behdasht.gov.ir/user/trial/76326/view ; Date of first registration: 19 May 2024.

Research Insights

  • Lactobacillus acidophilus→Improved Menopause Quality of Life

    the total MENQoL score was significantly lower in the probiotic group compared with placebo group (mean 25.1 vs. 30.9, P < 0.001).

    Effect
    Beneficial
    Effect size
    Moderate
    Dose
    250 mg capsule containing 3×10^9 CFU/cap once daily
  • Lactobacillus acidophilus→Improved Sexual Function

    After 8 weeks, the probiotic group had a significantly higher total FSFI score compared with the placebo group (median 19.1 vs. 18.2, P = 0.038).

    Effect
    Beneficial
    Effect size
    Small
    Dose
    250 mg capsule containing 3×10^9 CFU/cap once daily
Back to top